2009
New biologics for psoriasis and psoriatic arthritis
Rozenblit M, Lebwohl M. New biologics for psoriasis and psoriatic arthritis. Dermatologic Therapy 2009, 22: 56-60. PMID: 19222517, DOI: 10.1111/j.1529-8019.2008.01216.x.Peer-Reviewed Original ResearchConceptsPsoriatic arthritisPhase II studyNew biologic therapiesPrevalence of psoriasisSymptoms of psoriasisAlpha monoclonal antibodyTumor necrosis factorHuman tumor necrosis factorCertolizumab pegolBiologic therapyII studyJoint destructionInterleukin-23Rheumatoid arthritisInterleukin-12Radiographic evaluationTreatment optionsAlpha antibodyClinical trialsNecrosis factorNew biologicsArthritisPsoriasisMonoclonal antibodiesAntibodies
2003
Retrospective study of the efficacy of narrowband UVB and acitretin
Spuls P, Rozenblit M, Lebwohl M. Retrospective study of the efficacy of narrowband UVB and acitretin. Journal Of Dermatological Treatment 2003, 14: 17-20. PMID: 14578094, DOI: 10.1080/jdt.14.s2.17.20.Peer-Reviewed Original ResearchConceptsCombination of acitretinNarrowband UVBPlaque psoriasisUltraviolet BBroadband ultraviolet BLow-dose acitretinUVB three timesMajority of patientsUltraviolet B treatmentDose acitretinOral acitretinSerum lipidsTreat patientsTreat groupNumber of treatmentsRetrospective studyBroadband UVBRetrospective analysisAcitretinSide effectsUVB resultsPatientsPhototherapy treatmentMonotherapyPsoriasisTransition from methotrexate and cyclosporine to other therapies including retinoids, ultraviolet light and biologic agents in the management of patients with psoriasis
Maryles S, Rozenblit M, Lebwohl M. Transition from methotrexate and cyclosporine to other therapies including retinoids, ultraviolet light and biologic agents in the management of patients with psoriasis. Journal Of Dermatological Treatment 2003, 14: 7-16. PMID: 14578093, DOI: 10.1080/jdt.14.s2.7.16.Peer-Reviewed Original ResearchRetrospective study of the efficacy of narrowband UVB and acitretin
Spuls P, Rozenblit M, Lebwohl M. Retrospective study of the efficacy of narrowband UVB and acitretin. Journal Of Dermatological Treatment 2003, 14: 17-20. DOI: 10.1080/738528794.Peer-Reviewed Original ResearchConceptsCombination of acitretinNarrowband UVBPlaque psoriasisUltraviolet BBroadband ultraviolet BLow-dose acitretinUVB three timesMajority of patientsUltraviolet B treatmentDose acitretinOral acitretinSerum lipidsTreat patientsTreat groupNumber of treatmentsRetrospective studyBroadband UVBRetrospective analysisAcitretinSide effectsUVB resultsPatientsPhototherapy treatmentMonotherapyPsoriasis
2000
Transition from methotrexate and cyclosporine to other therapies including retinoids, ultraviolet light and biologic agents in the management of patients with psoriasis
Maryles S, Rozenblit M, Lebwohl M. Transition from methotrexate and cyclosporine to other therapies including retinoids, ultraviolet light and biologic agents in the management of patients with psoriasis. Journal Of Dermatological Treatment 2000, 14: 7-16. DOI: 10.1080/738528793.Peer-Reviewed Original ResearchTransition from methotrexate and cyclosporine to other therapies including retinoids, ultraviolet light and biologic agents in the management of patients with psoriasis
Maryles S, Rozenblit M, Lebwohl M. Transition from methotrexate and cyclosporine to other therapies including retinoids, ultraviolet light and biologic agents in the management of patients with psoriasis. Journal Of Dermatological Treatment 2000, 14: 7-16. DOI: 10.1080/753995509.Peer-Reviewed Original Research